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sample of 921 patients with schizophrenia collected in a 
nationwide Italian study, with the aim to identify, among a 
large set of personal resources, those that may have an asso-
ciation with symptom severity or psychosocial functioning. 
Abstract The relationships of personal resources with 
symptom severity and psychosocial functioning have never 
been tested systematically in a large sample of people with 
schizophrenia. We applied structural equation models to a 
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Several relevant demographic and clinical variables were 
considered concurrently. Poor service engagement and 
poor recovery style, as well as older age and younger age at 
onset, were related to greater symptom severity and poorer 
social functioning. Higher resilience and higher education 
were related to better social functioning only. Poor problem-
focused coping and internalized stigma, as well as male 
gender and depression, were related to symptom severity 
only. The explored variables showed distinctive and par-
tially independent associations with symptom severity and 
psychosocial functioning. A deeper understanding of these 
relationships may inform treatment decisions.
Keywords Schizophrenia · Personal resources · Symptom 
severity · Psychosocial functioning · Structural equation 
models
Introduction
Schizophrenia is a mental disorder often associated with 
poor functioning in several domains, including occupa-
tional and social functioning and independent living [1–4]. 
Symptom reduction and social functioning improvement 
are regarded as the two most important outcomes in schizo-
phrenia [3, 5, 6], but variations in one domain do not neces-
sarily correspond to a parallel variation in the other domain 
[7]. Studies investigating the relationship between psycho-
pathology and psychosocial functioning reported stronger 
correlations for negative symptoms than for positive symp-
toms, with depressive symptoms having a non-trivial role 
[6, 8, 9]. Personal resources such as recovery styles, resil-
ience, service engagement [10, 11], coping styles [11, 12], 
internalized stigma [13] and self-esteem [14] have been 
reported to interfere with both symptom reduction and 
social functioning.
Two distinct recovery styles, i.e., ‘integration’ and ‘seal-
ing over,’ have been defined [15–17]. Patients who employ 
the ‘sealing-over’ recovery style make significantly more 
negative self-evaluations and perceive their parents as sig-
nificantly less caring than those with the ‘integration’ style 
[11]. This latter style seems to favor recovery [16]. Resil-
ience is a construct whose exploration in schizophrenia is 
relatively recent. It is possibly related to functioning and 
to the transition from an at-risk state to psychosis [18], 
because it encompasses several aspects of personal, family 
and social resources. It has been defined as a personal trait 
protecting against mental disorders and as a dynamic pro-
cess of adaptation to challenging life conditions [19, 20]. 
Coping styles also influence the outcome of persons with 
severe mental illnesses, such as schizophrenia [21]. Emo-
tion-focused coping is more strongly and directly associ-
ated with symptom severity and poor quality of life than 
problem-focused coping [12]. Internalized stigma and poor 
self-esteem have also been reported to exert an unfavora-
ble influence on real-life functioning and quality of life [22, 
23], with implications for treatment.
Aim of the study
The aim of our study was to identify, among a set of per-
sonal resources in a large sample of patients with schizo-
phrenia, those that may have an association with symptom 
severity and/or with psychosocial functioning and that can 
inform and orient the treatment approach.
Materials and methods
Subjects
In the study of the Italian Network for Research on Psy-
choses [24], participants were recruited from patients living 
in the community and consecutively seen at the outpatient 
units of 26 Italian university psychiatric clinics and/or men-
tal health departments. Inclusion criteria were a diagnosis 
of schizophrenia according to DSM-IV, confirmed with the 
Structured Clinical Interview for DSM-IV—Patient version 
(SCID-I-P), and an age between 18 and 66 years. Exclusion 
criteria were: a history of head trauma with loss of con-
sciousness; a history of moderate to severe mental retarda-
tion or of neurological diseases; a history of alcohol and/
or substance abuse in the last 6 months; current pregnancy 
or lactation; inability to provide an informed consent; and 
treatment modifications and/or hospitalization due to symp-
tom exacerbation in the last 3 months.
All patients signed a written informed consent to par-
ticipate after receiving a comprehensive explanation of the 
study procedures and goals. Approval of the study protocol 
was obtained from the local ethics committees of each par-
ticipating center.
Procedures
Recruitment took place from March 2012 to September 
2013. A clinical form was filled in with data on age of onset 
of the first psychotic episode, course of the disease and treat-
ments, using all available sources of information (patient, 
family, medical records and mental health workers).
Study variables
Psychotic symptoms were assessed by means of the Posi-
tive and Negative Syndrome Scale (PANSS) 30-item rat-
ing scale [25]. Because several PANSS scores demon-
strated a different pattern of correlation with measures of 
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functioning, we adopted a new measure of global symp-
tom severity, derived from the PANSS items selected by 
the Remission in Schizophrenia Working Group (RSWG) 
to define remission in schizophrenia [26]. We obtained 
this measure by summing the scores of the following eight 
items: delusions (P1), conceptual disorganization (P2), 
hallucinatory behavior (P3), blunted affect (N1), social 
withdrawal (N4), lack of spontaneity (N6), mannering/
posturing (G5) and unusual thought content (G9). These 
items were chosen by the RSWG because they represent 
the three dimensions of psychopathology identified by fac-
tor analyses and the five criteria for schizophrenia specified 
in DSM-IV [26]. This variable was named PANSS Sever-
ity score (PANSS-Ss) and was considered as a continu-
ous proxy measure of remission/non-remission status. The 
original dichotomous formulation of RSWG symptomatic 
remission [26] was maintained only to analyze its rela-
tionship with psychosocial functioning and antipsychotic 
treatment.
Psychosocial functioning was measured using the Per-
sonal and Social Performance (PSP) scale [27]. Ratings 
are based on the assessment of four indicators: (1) socially 
useful activities, including work and study; (2) personal 
and social relationships; (3) self-care; and (4) disturbing 
and aggressive behaviors, rated on a six-point scale. The 
interviewer assigned a global score based upon information 
obtained during the interview regarding the four main areas 
of functioning and upon any additionally available source 
of information. The total score is usually divided into three 
levels: 71–100 (mild or no functioning difficulties); 31–70 
(varying degrees of difficulties); and 0–30 (functioning so 
poor that the patient needs intensive support and supervi-
sion) [5, 28].
Resilience was assessed using the Resilience Scale for 
Adults (RSA) [29, 30]. This self-administered instrument 
includes 33 items that examine intra- and inter-personal 
protective factors thought to facilitate adaptation when fac-
ing psychosocial adversity. Items are organized into six 
factors: perception of self, perception of the future, struc-
tured style, social competence, family cohesion and social 
resources. RSA total score was used as a global index of 
resilience with higher scores reflecting higher resilience.
The Service Engagement Scale (SES) [10] was used to 
explore patients’ relationship with mental health services. 
SES includes 14 items, rated on a 4-point Likert scale (with 
higher scores reflecting greater levels of difficulty engag-
ing with services), which are grouped into four subscales: 
availability, cooperation, help seeking and adherence to 
treatment. In the present paper, we used the total score.
The Internalized Stigma of Mental Illness (ISMI) [31] 
was used to evaluate the experience of stigma and internal-
ized self-rejection. It includes 29 items and 5 subscales for 
self-assessment of subjective experience of stigma. Each 
item is rated on a 4-level Likert scale, where higher scores 
indicate greater levels of internalized stigma.
Recovery style was measured with the Recovery Style 
Questionnaire (RSQ) [17] a 39-item self-report measure, 
designed to reflect categories consistent with those devel-
oped by McGlashan et al. [15]. Thirteen scales were com-
puted, with higher scores representing ‘integration’, i.e., a 
recovery style associated with better outcome, less depres-
sion and better self-evaluation, as compared to a ‘sealing-
over’ style [32].
The Self-Esteem Rating Scale (SERS) [14] was used to 
assess self-esteem. It consists of 40 items rated on a 7-point 
Likert scale, 20 scored positively and 20 negatively, with 
total scores ranging from −120 to +120. The SERS taps 
into multiple aspects of self-evaluation such as overall self-
worth, social competence, problem-solving ability, intel-
lectual ability, self-competence and worth compared with 
others. Higher scores represent higher self-esteem.
The extension of patients’ social network was assessed 
with the Social Network Questionnaire (SNQ). The ques-
tionnaire consists of 15 items exploring different aspects of 
social interactions which may be grouped into four factors 
representing social contacts, practical support, affective 
support and supporting partner [33]. Higher scores repre-
sent larger networks.
The Brief Cope, an abridged version of the Cope [34], 
is a self-report 14-subscale/28-item questionnaire that dem-
onstrated good psychometric properties in the assessment 
of dispositional as well as situational coping efforts. The 
14 subscales are composed of two items each with a higher 
score indicating greater use of the specific coping strategy. 
Problem-focused versus emotion-focused coping strategies 
were considered [35, 36].
Depressive symptoms were evaluated using the Calgary 
Depression Scale for Schizophrenia (CDSS), a rating scale 
designed to assess the level of depression in people with 
schizophrenia [37]. Higher scores represent higher levels of 
depression.
Statistical analyses
Continuous variables were summarized using mean and 
standard deviation (SD) and categorical variables as rela-
tive frequencies. Bivariate associations were analyzed 
between PSP and PANSS-Ss and between PANSS-Ss 
and PANSS subscales using correlation. Chi-square tests 
were used to evaluate the association between remission, 
levels of psychosocial functioning and antipsychotic 
treatment.
The relationship of symptom severity (PANSS-Ss) and 
psychosocial functioning (PSP) with a set of independent 
variables was analyzed using a structural equation model 
(SEM). The SEM framework has several advantages over 
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the more traditional multiple linear regression: First, esti-
mating a multivariate regression with two outcomes by a 
SEM instead than running two separate multiple regres-
sions leads to estimates that are more accurate, because the 
correlation between the outcomes may be accounted for. 
Independent variables can easily be identified as associated 
with a single outcome or with both outcomes by examining 
the graphical representation of SEM. The accuracy of the 
estimates can be improved by defining PSP as a latent vari-
able underlying the four PSP subscales, thus reducing the 
measurement error.
An initial full model including the relationships of all 
the independent variables with both outcomes was first 
tested. The final model was obtained by trimming one at 
a time, in decreasing order of p value, all nonsignificant 
relationships (p > 0.05) and removing variables which were 
unrelated to each of the outcomes. Removed variables may 
be either unrelated to the outcomes or highly correlated 
with at least another independent variable. Standardized 
coefficients were reported to allow the comparison of rela-
tionships pointing to the same dependent variable.
Stata 13.1 was used for descriptive statistics and Mplus 
7.4 was used for SEM analysis.
Results
Out of 1691 screened patients, 1180 were eligible; of these, 
202 refused to participate, 57 dropped out before complet-
ing the procedures, and 921 were included.
Descriptive statistics of demographic and clinical vari-
ables and of the outcomes are provided in Table 1.
Patients with symptomatic remission were 21.8 % of 
the study population. Of these patients, 11.8 % had no 
functioning difficulties, 78.3 % intermediate functioning 
and 9.9 % low functioning. Remission was significantly 
associated with no functioning difficulties (χ2 = 101.1; 
p < 0.001); 73.4 % of the samples were non-remitters 
with low functioning, 7.0 % were remitters with no 
functioning difficulties, 14.8 % remitters with low func-
tioning and 4.8 % non-remitters with no functioning 
difficulties.
Among patients with 71–100 PSP score, 13.8 % were on 
second-generation antipsychotics (SGA), while 6.1 % were 
on first-generation antipsychotics (FGA). Patients with 
0–30 PSP score were for 7.9 % on SGA and for 19.2 % on 
FGA.
The association between type of antipsychotics and 
PSP was statistically significant (χ2 = 30.20; p < 0.0001). 
Among remitters, 16.5 % were on SGA and 0.9 % on FGA, 
while non-remitters 59.1 % were on SGA and 13.3 % were 
on FGA. The remaining patients were on both SGA and 
FGA or off (χ2 = 13.81, p = 0.003).
Correlations of PANSS-Ss with PANSS total score were 
r = 0.923, with PANSS positive r = 0.774; with PANSS 
negative r = 0.800.
PSP correlation with PANSS positive was r = −0.391, 
with PANSS negative r = −0.485 and with PANSS total 
r = −0.515.
Relationships of personal resources with psychosocial 
functioning and symptom severity
The initial SEM model, including all the relationships 
between the independent variables and the two dependent 
Table 1  Characteristics of the study population
PANSS Positive and Negative Syndrome Scale, PSP Personal and 
Social Performance Scale, SES Service Engagement Scale, RSA 
Resilience Scale for Adults, RSQ Recovery Style Questionnaire, 
SERS Self-Esteem Rating Scale, ISMI Internalized Stigma of Mental 
Health, SNQ Social Network Questionnaire, CDSS Calgary Depres-
sion Scale for Schizophrenia
a Not included in the SEM models
Variable n Mean (SD) or %
Education (years) 919 11.61 (3.43)
Age 921 40.17 (10.71)
Age at onset 918 24.02 (7.20)
Antipsychotics treatment
 First-generation antipsychotics 630 68.6 %
 Second-generation antipsychotics 130 14.1 %
 Both 13 14.1 %
 None 29 3.2 %
Gender (% males) 921 69.6 %
Worka (% working) 893 29.2 %
PANSS positivea 920 16.12 (6.74)
PANSS negativea 920 21.93 (8.52)
PANSS general psychopathologya 920 37.44 (11.81)
PANSS totala 920 75.49 (23.05)
PANSS severity 921 21.94 (7.81)
RSA total 921 106.56 (21.30)
PSP totala 919 52.99 (16.55)
PSP activities 920 −2.43 (1.20)
PSP relationships 919 −2.46 (1.06)
PSP self-care 920 −1.07 (1.05)
PSP aggressive behavior 920 −0.54 (0.88)
Problem-focused coping 921 39.68 (10.51)
Emotion-focused coping 921 24.95 (6.16)
SES 921 12.89 (7.71)
RSQ 909 7.99 (2.23)
SERS 921 16.01 (40.65)
ISMI 910 2.20 (0.44)
SNQ 911 2.28 (0.50)
CDSS 920 3.99 (4.02)
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variables, is depicted in Fig. 1. All the four PSP scales had 
significant loadings on the latent PSP factor (p < 0.001), 
ranging from 0.409 to 0.685. Significant correlations 
were found between the latent PSP and symptom severity 
(r = −0.514, p < 0.001) and between PSP activities and 
PSP relationships (r = 0.311, p < 0.001) and were added 
to the model. This model proved to have a satisfactory 
goodness of fit to the data: RMSEA = 0.043, CFI = 0.948, 
TLI = 0.909.
The final SEM model is shown in Fig. 2. Emotion-
focused coping, SERS and SNQ were unrelated to both 
outcomes and were removed from the model.
Of the remaining variables, RSQ and SES, as well as age 
and age at onset, were related to both outcomes; problem-
focused coping and ISMI, as well as gender and CDSS, 
were related only to symptom severity; and education and 
RSA were related only to PSP (Table 2). The variables 
with the strongest association with higher symptom sever-
ity were lower service engagement (b = 0.202, p < 0.001) 
and younger age at onset (b = −0.180, p < 0.001). Other 
significant associations were found with higher internalized 
stigma, less effective recovery style, less problem-focused 
coping, more severe depression, older age and male gen-
der. A better psychosocial functioning was associated 
with lower service engagement (b = −0.267, p < 0.001), 
younger age (b = −0.304, p < 0.001), older age at onset 
(b = 0.277, p < 0.001), higher resilience, higher levels of 
education and a more effective recovery style. Three PSP 
scales, i.e., PSP activities, PSP relationships and PSP self-
care, showed high loadings on the latent factor PSP (from 
0.600 to 0.676), while PSP aggressive behavior scale 
loading was 0.418. Significant correlations were con-
firmed between symptom severity and PSP (r = −0.517, 
p < 0.001) and between PSP activities and PSP relation-
ships (r = 0.329, p < 0.001). Only six estimated correla-
tions between pairs of predictors were above 0.2, namely 
those between ISMI and RSA (r = 0.499), age and age 
at onset (r = 0.349), problem-focused coping and RSA 
(r = 0.309), ISMI and CDSS (r = 0.296), RSA and CDSS 
(r = −0.285) and problem-focused coping and RSQ 
(r = 0.281).
Model fit was good and improved over the initial model, 
with RMSEA = 0.039, CFI = 0.958 and TLI = 0.937. 
The explained variances of the outcomes were 0.170 for 
PANSS-Ss and 0.297 for PSP. Due to some sparse miss-
ing data on the independent variables, the model was tested 
on 902 patients with complete data (missing data propor-
tion was 19/921 = 2.1 %). This sample size was more than 
Fig. 1  Diagram of the initial SEM. Rectangles indicate observed 
variables; the ellipsis indicates that PSP is a latent variable with 
arrows pointing to its indicators. Straight arrows from the independ-
ent observed variables on the left to symptom severity and to PSP 
indicate regressions; small straight arrows on the dependent variables 
indicate the presence of residuals; curved arrows linking residuals 
indicate correlations. RSA Resilience Scale for Adults, ISMI Internal-
ized Stigma of Mental Health, SERS Self-Esteem Rating Scale, RSQ 
Recovery Style Questionnaire, SES Service Engagement Scale, SNQ 
Social Network Questionnaire, CDSS Calgary Depression Scale for 
Schizophrenia, PSP Personal and Social Performance Scale
 Eur Arch Psychiatry Clin Neurosci
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adequate to estimate the 30 free parameters of the final 
model.
Discussion
To our knowledge, this is the first study examining the rela-
tionships of personal resources with symptom severity and 
psychosocial functioning in a large sample of patients with 
schizophrenia.
Despite the wide literature on PANSS factors, no sin-
gle model achieved broad consensus [38]. To have a more 
global index of core symptom severity, we decided to use 
a new PANSS measurement obtained by summing all item 
scores selected by Andreasen et al. [26] in the Remission 
in Schizophrenia Working Group (RSWG). These items 
were chosen because they reflect the three dimensions of 
psychopathology in schizophrenia, overcoming the factor-
analytic debate.
PSP has been used as a measure of social functioning in 
patients with stable schizophrenia with well-reported reli-
ability and validity [5].
We found that some variables were associated with both 
PANSS-Ss and PSP (i.e., age, age at onset, service engage-
ment and recovery style); some were associated with PSP 
only (i.e., resilience and educational level); and others 
were associated with PANSS-Ss only (i.e., gender, problem 
focus coping, internalized stigma and depression).
As expected, correlations between PANSS scores and 
PSP were negative [6, 28, 39, 40]. The strongest one was 
the correlation between PANSS-Ss and PSP. This was 
even higher than the widely reported correlations of PSP 
with the PANSS negative factor and the PANSS total score 
[6], suggesting that the PANSS-Ss may have a strong face 
validity.
The significant association of service engagement with 
the severity of symptom and with psychosocial function-
ing is a new finding. Service engagement is a useful tool 
for research and clinical purposes [10]. Individuals who 
are experiencing difficulties in engaging with services have 
poorer outcomes (i.e., higher severity of symptoms and 
poorer psychosocial functioning). This domain could be a 
target of further attention.
An interesting difference was found between the two 
outcomes with regard to their association with the symp-
toms of depression, which were related to PANSS-Ss but 
not to PSP. Depression could represent a nonspecific symp-
tom limiting psychosocial functioning improvement [24, 
41, 42], and several studies reported persisting symptoms 
of depression associated with reduced quality of life and 
Fig. 2  Diagram of the final SEM. Rectangles indicate observed vari-
ables; the ellipsis indicates that PSP is a latent variable with arrows 
pointing to its indicators. Straight arrows from the independent 
observed variables on the left to symptom severity and to PSP indi-
cate regressions, with numbers showing the estimated standardized 
regression coefficients; small straight arrows on the dependent vari-
ables indicate the presence of variance residuals, with numbers show-
ing the explained variance; curved arrows linking residuals indicate 
correlations, with numbers showing the estimated coefficients. RSA 
Resilience Scale for Adults, ISMI Internalized Stigma of Mental 
Health, RSQ Recovery Style Questionnaire, SES Service Engagement 
Scale, CDSS Calgary Depression Scale for Schizophrenia, PSP Per-
sonal and Social Performance Scale
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functioning [43, 44]. However, most of the studies that 
investigated the relationship between depression and psy-
chosocial functioning utilized bivariate instruments, not 
considering other factors that could be associated with psy-
chosocial functioning and related to depression.
The association of depression with severity of symptoms 
could also be the consequence of more severe symptoms 
inducing a demoralizing effect. Unfortunately, the cross-
sectional design of the study cannot clarify the meaning of 
the reported association.
Either depression or low self-esteem could interact with 
stigma, as reported by Lysaker et al. [22], limiting symp-
tom improvement. Our results indicate that internalized 
stigma is significantly associated with symptom severity 
but not with PSP. As recently reviewed by Gerlinger et al. 
[45], personal stigma (i.e., self- stigma) is well character-
ized, but stigma correlates differ remarkably. Social func-
tioning was reported to show ambiguous associations with 
personal stigma that otherwise shows a significant correla-
tion with positive symptoms and general psychopathology 
[45, 46]. Our findings confirm the latter observations.
The association between stigma and more severe symp-
toms [22, 46, 47] addresses the issue of possible strategies 
aimed at stigma reduction. van Zelst et al. [48] reported 
that enhancing psychological resources, by increasing 
self-esteem and the ability to cope with symptoms, could 
improve stigma resilience.
Research into recovery in psychosis has shown that 
people with a diagnosis of schizophrenia often use avoid-
ance coping strategies rather than problem-focused ones 
[11, 16, 17, 49]. We report that problem-focused but not 
emotion-focused coping strategies were associated with a 
lower severity of symptoms. Although there is no consen-
sus regarding which coping strategies are most effective in 
reducing psychopathological and distress symptoms [50], 
researchers have found that patients with schizophrenia 
tend to use ineffective emotionally oriented or non-prob-
lem-focused coping styles [22, 49, 51]. Our findings sug-
gest that treatment strategies aiming to enhance the coping 
of individuals with psychosis could ultimately reduce the 
severity of symptoms [49].
This study builds on previous work [17] examining the 
hypothesis that recovery styles could predict outcomes. 
Interestingly, recovery styles (i.e., integration) are associ-
ated with both psychosocial functioning and symptom 
severity.
A relatively new finding is the relationship of resilience 
with psychosocial functioning. Torgalsbøen [20] reported a 
significant correlation between resilience and present psy-
chosocial functioning and a significant difference between 
fully recovered individuals and those in remission regard-
ing their resilience score. Mirroring the problem-focused 
coping, we found an association of resilience with social 
functioning but not with severity of symptoms, suggest-
ing that slight but meaningful differences between coping, 
resilience and recovery styles exist. This finding could help 
to further refine these constructs in the broad area of remis-
sion/recovery/functioning in schizophrenia.
Our results indicate that some demographic and clini-
cal variables, such as age and age at onset, were associated 
with both the severity of symptoms and psychosocial func-
tioning, while gender was related to severity of symptoms 
only. The association between symptom severity and older 
age, as well as the relationship of older age at onset and 
female gender with lower symptom severity, confirms find-
ings from previous reports [43, 52–54]. The association 
of poorer functioning with younger age and lower age at 
onset is a well-established finding [55] and is in line with 
our results.
Educational level has been historically considered a pre-
dictor of social and work functioning [40, 56–58], and we 
confirm this finding.
For social and everyday living outcomes, variance 
accounted for by the entire array of predictive variables 
Table 2  Results of the final SEM
PANSS Positive and Negative Syndrome Scale, PSP Personal and 
Social Performance Scale, SES Service Engagement Scale, RSA 
Resilience Scale for Adults, RSQ Recovery Style Questionnaire, ISMI 
Internalized Stigma of Mental Health, CDSS Calgary Depression 
Scale for Schizophrenia
b = standardized regression coefficient
Dependent and independent variables b p value
Measurement model (PSP on PSP subscales)
PSP activities 0.674 <0.001
PSP relationships 0.600 <0.001
PSP self-care 0.676 <0.001
PSP aggressive behavior 0.418 <0.001
Outcome PANSS-Ss
Gender 0.064 0.023
Age 0.151 <0.001
Age at onset −0.180 <0.001
Problem-focused coping −0.065 0.026
ISMI 0.097 0.002
CDSS 0.138 <0.001
RSQ −0.089 0.005
SES 0.202 <0.001
Outcome PSP
Education 0.089 0.010
Age −0.304 <0.001
Age at onset 0.277 <0.001
RSA 0.152 <0.001
RSQ 0.089 0.015
SES −0.267 <0.001
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was less than 30 %, suggesting that other factors, such as 
social and cultural influences, are involved as well [9, 24].
The issue of differences between first- versus second-
generation antipsychotics on measure of functioning is still 
open for debate [59, 60] so that the differences in the asso-
ciation between psychosocial function and antipsychotic 
treatment that we reported deserve further investigations 
either for the considerable pharmacologic heterogeneity 
within and between the FGA and SGA groups or for the 
cross-sectional design of the study that impedes any causal 
interpretation of the findings. The cross-sectional nature 
of this study constitutes important limitation and prevents 
conclusions regarding the causality of findings. The major 
strengths of the study are the large size of the sample 
and the wide array of state-of the-art instruments, which 
allowed the use of a multivariate model in a SEM frame-
work to test the associations among a large number of vari-
ables with high reliability.
In conclusion, our results indicate that personal 
resources, clinically relevant demographic features (i.e., 
age at onset and gender) and non-core symptoms, such as 
depression, are significantly associated with either severity 
of symptoms or psychosocial functioning or with both out-
comes, but with different loadings.
The results of the current study might inform psycho-
social treatments aimed to reduce stigma, improve coping 
strategies and shape recovery styles. Some of these factors 
are potentially modifiable by specific therapeutic interven-
tions, which can produce considerable clinical and func-
tional improvements.
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